[SYRE] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- -4.96%
YoY- -91.41%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -18,728 -21,495 -21,573 -18,019 -17,167 -14,898 -11,917 35.13%
Tax 0 0 0 0 0 0 0 -
NP -18,728 -21,495 -21,573 -18,019 -17,167 -14,898 -11,917 35.13%
Tax Rate - - - - - - - -
Total Cost 18,728 21,495 21,573 18,019 17,167 14,898 11,917 35.13%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -14.15 0.00 -16.40 -13.72 -14.79 0.00 -13.55 2.92%
EPS Diluted -14.15 0.00 -16.40 -13.72 -14.79 0.00 -13.55 2.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.